Table:
begin	end	state
1	25	cytoplasmic
26	51	transmembrane
52	60	non-cytoplasmic
61	82	transmembrane
83	93	cytoplasmic
94	113	transmembrane
114	118	non-cytoplasmic
119	140	transmembrane
141	151	cytoplasmic
152	172	transmembrane
173	183	non-cytoplasmic
184	205	transmembrane
206	262	cytoplasmic
263	289	transmembrane
290	302	non-cytoplasmic
303	326	transmembrane
327	335	cytoplasmic
336	356	transmembrane
357	368	non-cytoplasmic
369	394	transmembrane
395	405	cytoplasmic
406	433	transmembrane
434	435	non-cytoplasmic
436	456	transmembrane
457	499	cytoplasmic

Input:
>BWI76_RS03110
MSKEQYLTLNKASGPNSETPTTPFVKVVALIATLGGLLFGYDTGVISGALLFMGTELHLT
PFTTGLVTSSLLFGAAFGALLSGNLANAAGRKKIILWLAVLFAIGAIGTSMAPDVNWMIF
FRLILGVAVGGAAATVPVYIAEIAPANKRGQLVTLQELMIVSGQLLAYISNATFHEVWGG
ESTWRWMLAVATLPAVLLWFGMMFMPDSPRWYAMKGRLAEARRVLERTRHKDDVEWELLE
ITETLDEQRNLGKPRFSEIMTPWLFKLFMIGIGIAVIQQLTGVNTIMYYAPTVLTSVGMT
DNAALFATIANGVVSVLMTFVGIWMLGKIGRRPMTMIGQFGCTACLVFIGAVSYLLPETV
NGQPDALRAYMVLAGMLLFLSFQQGALSPVTWLLMSEIFPTRLRGIFMGGAVFSMWIANF
LISLFFPILLAWLGLSGTFFIFAGIGVFGAIFVIKCVPETRHRSLEQIEHYLRDKLDTSE
EGQAARARRIVAESQANKV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server